Evidence map›Paper›PMID 27206552›Full record

ArticleTissue engineering. Part C, Methods2016

In Vitro Endothelialization of Biodegradable Vascular Grafts Via Endothelial Progenitor Cell Seeding and Maturation in a Tubular Perfusion System Bioreactor.

Anthony J Melchiorri, Laura G Bracaglia, Lucas K Kimerer, Narutoshi Hibino, John P Fisher

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part C, Methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Tissue engineering: Relevance to neonatal congenital heart disease.Seminars in fetal & neonatal medicine · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anthony J Melchiorri1 Fischell Department of Bioengineering, University of Maryland , College Park, Maryland.
Laura G Bracaglia1 Fischell Department of Bioengineering, University of Maryland , College Park, Maryland.
Lucas K Kimerer1 Fischell Department of Bioengineering, University of Maryland , College Park, Maryland.
Narutoshi Hibino2 Department of Surgery & Cardiac Surgery, Johns Hopkins University School of Medicine , Baltimore, Maryland.
John P Fisher1 Fischell Department of Bioengineering, University of Maryland , College Park, Maryland.
University of Maryland, College Park · USJohns Hopkins University · US

Funding

Application of Tubular Perfusion System (TPS) Generated Prevascularized Bone TissR01AR061460 · NIAMS · UNIV OF MARYLAND, COLLEGE PARK · PI FISHER, JOHN P · 2011 to 2014
$1.3M
NIAMS NIH HHS R01 AR061460
6 · The paper itself

Abstract

A critical challenge to the success of biodegradable vascular grafts is the establishment of a healthy endothelium. To establish this monolayer of endothelial cells (ECs), a variety of techniques have been developed, including cell seeding. Vascular grafts may be seeded with relevant cell types and allowed to mature before implantation. Due to the low proliferative ability of adult ECs and issues with donor site morbidity, there has been increasing interest in using endothelial progenitor cells (EPCs) for vascular healing procedures. In this work, we combined the proliferative and differentiation capabilities of a commercial cell line of early EPCs with an established bioreactor system to support the maturation of cell-seeded vascular grafts. All components of the vascular graft and bioreactor setup are commercially available and allow for complete customization of the scaffold and culturing system. This bioreactor setup enables the control of flow through the graft, imparting fluid shear stress on EPCs and affecting cellular proliferation and differentiation. Grafts cultured with EPCs in the bioreactor system demonstrated greatly increased cell populations and neotissue formation compared with grafts seeded and cultured in a static system. Increased expression of markers for mature endothelial tissues were also observed in bioreactor-cultured EPC-seeded grafts. These findings suggest the distinct advantages of a customizable bioreactor setup for the proliferation and maturation of EPCs. Such a strategy may be beneficial for utilizing EPCs in vascular tissue engineering applications.

Indexed as

BioreactorsBlood Vessel ProsthesisCell DifferentiationCell ProliferationCells, CulturedEndothelial Progenitor CellsEndothelium, VascularHumansStress, MechanicalTissue Engineering

Identifiers

PMID27206552
PMCPMC4943466
OpenAlexW2398245718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.